Coordinated SpeechXRays (multi-channel biometric analysis), contributed to SMILE (smart border identity checks), and iMARS (ID document fraud detection).
IDEMIA FRANCE
Global identity and security company specializing in biometrics, ID document fraud detection, and cybersecurity for critical infrastructure.
Their core work
IDEMIA France (formerly Oberthur Technologies) is a global identity and security company specializing in biometric authentication, digital identity management, and cybersecurity solutions. In EU research, they bring deep industrial expertise in multi-modal biometrics, secure hardware evaluation, smart border systems, and ID document fraud detection. Their contributions span from developing biometric fusion algorithms to securing IoT systems and healthcare infrastructure against cyber threats.
What they specialise in
Contributed to PANACEA (hospital cybersecurity), InSecTT (secure IoT systems), and ISOLA (onboard security for passenger ships).
Participated in REASSURE (side-channel and fault attack resilience) and SECREDAS (cyber security for automated systems).
Participated in i3-MARKET, developing trusted and secure data marketplace infrastructure.
Contributed to ISOLA (passenger ship security) and SMILE (land border security systems).
How they've shifted over time
IDEMIA's early H2020 work (2015-2018) centered on core identity technology — multi-modal biometrics (SpeechXRays), hardware security evaluation (REASSURE), and smart border control (SMILE). From 2019 onward, their focus broadened significantly into applied cybersecurity across healthcare, maritime, and IoT domains, alongside new interests in data economy infrastructure and AI trustworthiness. This shift reflects a company moving from component-level security R&D toward system-level cybersecurity solutions for specific industry verticals.
IDEMIA is expanding from pure identity/biometrics technology into cybersecurity solutions for healthcare, maritime, and IoT sectors — making them relevant to a wider range of security-focused consortia.
How they like to work
IDEMIA mostly joins consortia as a participant or third party rather than leading them — they coordinated only 1 of 9 projects (SpeechXRays, their largest funded effort). With 226 unique partners across 28 countries, they operate as a specialist contributor embedded in large European consortia. Their frequent third-party role (4 projects) suggests they often provide specific industrial components or validation capabilities without being a core consortium member.
Extensive European network with 226 unique consortium partners spread across 28 countries, reflecting their position as a major industrial player that large security and digital consortia seek out for specific expertise. No strong geographic concentration — partnerships span broadly across the EU.
What sets them apart
IDEMIA brings rare industrial-grade expertise in identity technologies — few companies combine biometric R&D, secure hardware evaluation, and ID document fraud detection under one roof. Their dual capability in both physical identity (biometrics, document verification) and digital security (cybersecurity, secure IoT) makes them a uniquely versatile partner for projects requiring end-to-end identity and security solutions. As a large private company, they can provide real-world deployment environments and commercial validation that academic partners cannot.
Highlights from their portfolio
- SpeechXRaysTheir only coordinated project and largest funded effort (EUR 993K), combining acoustic and visual biometric analysis — a signature capability for IDEMIA.
- PANACEARepresents their expansion into healthcare cybersecurity, covering threat assessment, privacy by design, and blockchain-based security for hospitals.
- iMARSDirectly aligned with IDEMIA's core business — detecting image manipulation and morphing attacks on ID documents, a growing concern in border security.